The pharmaceutical industry is on the cusp of a transformation, driven by cutting-edge technologies like 3D printing. GMP, a leading UK-based contract manufacturer specializing in pharmaceuticals, cosmetics, and healthcare products, is pioneering this shift.

With a platform that combines hardware, software, and formulation solutions, GMP enables customizable, small-batch medicines tailored to individual needs. 

What does this mean for the future of personalized medicine?

Here’s our conversation with Giby George, Group CEO, GMP